TD Private Client Wealth LLC reduced its stake in MetLife, Inc. (NYSE:MET – Free Report) by 5.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 60,132 shares of the financial services provider’s stock after selling 3,455 shares during the quarter. TD Private Client Wealth LLC’s holdings in MetLife were worth $4,924,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Sierra Ocean LLC acquired a new position in MetLife in the 4th quarter worth approximately $32,000. Retirement Wealth Solutions LLC acquired a new position in MetLife in the 4th quarter worth approximately $32,000. Values First Advisors Inc. acquired a new position in MetLife in the 4th quarter worth approximately $36,000. Bank Julius Baer & Co. Ltd Zurich acquired a new position in MetLife in the 4th quarter worth approximately $48,000. Finally, Golden State Wealth Management LLC acquired a new position in MetLife in the 4th quarter worth approximately $44,000. 94.99% of the stock is owned by hedge funds and other institutional investors.
MetLife Price Performance
MetLife stock opened at $82.33 on Friday. The company’s fifty day moving average price is $83.48 and its 200 day moving average price is $82.60. MetLife, Inc. has a 1 year low of $67.30 and a 1 year high of $89.05. The stock has a market capitalization of $56.09 billion, a P/E ratio of 13.79, a P/E/G ratio of 0.65 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.
MetLife Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th were issued a $0.545 dividend. The ex-dividend date was Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.65%. MetLife’s payout ratio is currently 36.52%.
Analyst Ratings Changes
Several equities analysts recently weighed in on the stock. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $100.00 to $98.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 12th. Wells Fargo & Company raised their price objective on shares of MetLife from $92.00 to $97.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 19th. BMO Capital Markets assumed coverage on shares of MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price objective on the stock. Finally, JPMorgan Chase & Co. raised their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $94.58.
View Our Latest Stock Report on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is Short Interest? How to Use It
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Expert Stock Trading Psychology Tips
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.